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Retroviral overexpression of reprogramming factors
(Oct4, Sox2, Klf4, c-Myc) generates induced pluripo-
tent stem cells (iPSCs). However, the integration of
foreign DNA could induce genomic dysregulation.
Cell-permeant proteins (CPPs) could overcome this
limitation. To date, this approach has proved ex-
ceedingly inefficient. We discovered a striking differ-
ence in the pattern of gene expression induced by
viral versus CPP-based delivery of the reprogram-
ming factors, suggesting that a signaling pathway
required for efficient nuclear reprogramming was
activated by the retroviral, but not CPP approach.
In gain- and loss-of-function studies, we find that
the toll-like receptor 3 (TLR3) pathway enables effi-
cient induction of pluripotency by viral or mmRNA
approaches. Stimulation of TLR3 causes rapid and
global changes in the expression of epigenetic modi-
fiers to enhance chromatin remodeling and nuclear
reprogramming. Activation of inflammatory path-
ways are required for efficient nuclear reprogram-
ming in the induction of pluripotency.INTRODUCTION
Seminal studies by Yamanaka and colleagues revealed that
ectopic expression of four transcriptional factors (Oct4, Sox2,
Klf4 and c-Myc; OSKM) induces pluripotency in somatic cells
(Takahashi et al., 2007; Takahashi and Yamanaka, 2006). How-
ever, much remains to be understood about the underlying
mechanisms of reprogramming of somatic cells to iPSCs. Fur-
thermore, retroviral overexpression of the reprogramming fac-
tors raises concerns that the integration of foreign DNA into the
host genome could silence or induce dysregulation of indispens-
able genes (Maherali et al., 2007; Okita et al., 2007; Takahashiet al., 2007; Takahashi and Yamanaka, 2006; Wernig et al.,
2007). A protein-based approach for iPSC generation avoids
all concerns for integration of foreign DNA and theoretically
provides for greater control over the concentration, timing, and
sequence of transcription factor stimulation (Yang et al., 2009;
Zhou et al., 2009). Successful reprogramming to pluripotency
has been achieved by using purified recombinant proteins or
cell extracts containing these proteins, but is exceedingly in-
efficient (Cho et al., 2010; Kim et al., 2009; Zhou et al., 2009)
(0.001%) by comparison to reprogramming with retroviral vec-
tors (0.1%–1%) (Stadtfeld and Hochedlinger, 2010). In seeking
to develop effective reprogramming protocols with cell-perme-
ant proteins (CPPs), we fortuitously observed an intriguing
difference in the pattern of gene expression induced by viral,
as opposed to CPP-based, methods. The accelerated and
sustained induction of gene expression that is observed with
retroviral methodology is recapitulated by combining CPPs
with retroviral particles encoding nonrelevant genes or more
practically by combining CPPs with agonists of toll-like recep-
tors (TLRs). We further observed that the induction of toll-
like receptor 3 (TLR3)-mediated signaling promotes epigenetic
remodeling that is generally required for efficient reprogram-
ming. Recognition of the role of innate immunity in nuclear
reprogramming, and its directed manipulation, provides key
insights that may facilitate our understanding of both innate
immunity and reprogramming and increase our understanding
of the genetic and epigenetic pathways that function in induced
pluripotency.
RESULTS
Different Patterns of Gene Expression Induced by
Reprogramming Factors Delivered as Viral Constructs
versus Cell-Permeant Peptides
The CPPs are fusion peptides, each with a reprogramming fac-
tor, a linker, and a cell transduction domain (Yang et al., 2009).
These CPPs exhibit cognate DNA-binding activity, rapidly trans-
locate across the plasma and nuclear membranes, uniformlyCell 151, 547–558, October 26, 2012 ª2012 Elsevier Inc. 547
Figure 1. Irrelevant Retroviral Vector Accelerates CPP-Induced Gene Expression
Changes in expression of pluripotency genes were assessed after exposure of human fibroblasts to the retroviral vectors encoding Sox2 or Oct4 or the cell
permeant peptides of Sox2 or Oct4. The addition of an irrelevant retroviral vector encodingGFP (pMX-GFP) enhanced the response to the cell permeant peptides.
(A) Relative fold change in gene expression levels of Nanog after exposure to pMX-Sox2 (red line), CPP-SOX2 (blue line), or pMX-GFP + CPP-SOX2 (green line).
Relative fold change in gene expression was determined following treatment with 200 nM CPP-SOX2 daily or after a single pMX-Sox2 infection on day 0. All data
represented as mean ± S.D., n = 3, *p < 0.005.
(B) Summary figure showing the average fold-change in the selected genes (i.e., Jarid2, Zic2, bMyb,Oct4, Sox2, and Nanog) over time for each condition. When
Sox2 is given in the form of a CPP, activation of the downstream target genes is delayed. However, in the presence of an irrelevant retroviral vector, target gene
expression increases rapidly and mimics that of pMX-Sox2.
(C) Relative fold change in gene expression levels of Nanog following pMX-Oct4, CPP-OCT4, or pMX-GFP + CPP-OCT4 treatments.
(D) Summary figure showing the average fold-change in the selected genes (i.e., Tcf4, Gap43, Nanog, Sox2, and Oct4) over time for each condition. All data
represented as mean ± S.D., n = 3, *p < 0.005 (see also Figures S1 and S2).transduce nearly all cells in the treated wells, and exert tran-
scriptional control on known downstream target genes. Never-
theless, after multiple attempts with a variety of experimental
protocols, we initially failed to generate iPSC lines from human
fibroblasts by using CPPs generated by our group or by com-
mercial vendors.
In an effort to understand and overcome this hurdle, we
examined the temporal sequence of target gene expression in
response to a retroviral construct (pMX-Sox2) versus the corre-
sponding CPP (CPP-SOX2). We focused on validated down-
stream targets such as Jarid2, Zic2, and bMyb for Sox2-acti-
vated genes, as well as, downstream genes known to function
in nuclear reprogramming, i.e., Nanog, Sox2, and Oct4 (Boyer
et al., 2006; Li et al., 2010; Sharov et al., 2008; Tarasov et al.,
2008). Human fibroblasts were synchronized by serum starva-
tion and then subjected to either a single infection with pMX-
Sox2 or daily treatments of CPP-SOX2, and gene expression
was assayed up to 20 days. We used a daily dose of CPP-
SOX2 (200 nM) that we had shown could rescue human iPSCs
treated with shRNA against Sox2 (data not shown).548 Cell 151, 547–558, October 26, 2012 ª2012 Elsevier Inc.An intriguing difference in the pattern of gene expression
was observed. As early as day 1 of transfection with pMX-
Sox2, human BJ fibroblasts manifested increased expression
of the pluripotency (e.g., Nanog) and target genes (Figures 1A
and 1B and Figure S1 available online). By contrast, despite
its rapid entry into the cytoplasm and nucleus of treated cells
(within 2 hr; data not shown), CPP-SOX2 did not show a similar
increase in target gene expression in the first 48 hr (Figure 1A).
Because the temporal pattern of expression of the selected
genes (Jarid2, Zic2, bMyb,Oct4, Sox2, and Nanog) was remark-
ably similar for each treatment condition, their change in fold-
expression over time is shown as an average in Figure 1B.
The observed difference in target gene expression occurred
despite high transfection efficiency with the CPP (over 80%;
data not shown).
To exclude the possibility that the delay in target gene expres-
sion was a function of the design of a single CPP, we repeated
these experiments comparing a CPP versus viral vector for
Oct4 (pMX-Oct4), assessing the effect on downstream targets
(Tcf4 andGAP43) and pluripotency genes.We observed a similar
pattern of delayed gene expression in cells treated with CPP-
OCT4 compared to those transfected with pMX-Oct4 (Figures
1C and 1D). Again, because the temporal pattern of expression
of the selected genes was remarkably similar for each treatment
condition, their change in fold-expression over time is shown
as a group average in Figure 1D. Thus, the pattern of delayed
expression of downstream target genes appeared to be an attri-
bute of CPP reprogramming factors. To determine whether this
difference in gene expression was attributable to the temporal
differences in the expression levels of the reprogramming factors
between the two delivery methods, we quantified the nuclear
expression of Oct4 after CPP or retroviral delivery of Oct4
(data not shown). Both of the delivery methods showed equal
expression of Oct4 at 24 hr posttreatment.
To further determine the role of CPPs on induction of pluripo-
tency, we checked the gene expression of pluripotency factors
at later time points (days 4–20). Retroviral Oct4 induced an
exponential increase in pluripotency gene expression at later
time points (Figures S2A–S2C). In contrast, after an initial delay,
CPP-OCT4 induced only amodest increase in pluripotency gene
expression (‘‘low and slow’’).
Viral Particles Accelerate and Augment CPP-Induced
Expression of Target Genes
We hypothesized that an intrinsic feature of viral particles, inde-
pendent of the genes encoded, might influence the reprogram-
ming process. To test this hypothesis, we assessed the effect of
the CPPs alone or in the presence of a retroviral particle encod-
ing a gene not involved in reprogramming. The pMX-GFP
control vector did not affect target gene expression (Fig-
ure S1C). However, when the pMX-GFP vector was combined
with CPP-SOX2, the expression of the Sox2 target genes was
enhanced substantially. In fact, the combination reproduced
the pattern of gene expression induced by the retrovirus
expression vector pMX-Sox2 (Figures 1A and 1B and Figures
S1A and S1B). We repeated these studies with CPP-OCT4
(Figures 1C and 1D and Figures S1D and S1E). When the
pMX-GFP vector was combined with CPP-OCT4, again the
temporal expression of the downstream genes was acceler-
ated, mimicking the effect observed with the viral vector pMX-
Oct4 (Figures 1C and 1D). These studies suggested that some
intrinsic feature of the viral particle contributed to nuclear
reprogramming.
Mechanism by which Viral Particles Enable
CPP-Induced Expression of Target Genes
To gain more insight into the mechanisms by which a ret-
roviral particle could accelerate nuclear reprogramming, we
substituted a nonintegrating mutant of pMX-GFP by introducing
a frameshift mutation near the pol coding region of the retrovirus
(Hagino-Yamagishi et al., 1987). Notably, the pMX-GFP noninte-
grating mutant was fully capable of accelerating the target gene
expression induced by CPP-OCT4 (Figures S1F–S1J). Accord-
ingly, integration of foreign DNA into the host genome is not
required for the difference in gene expression between the
CPPs and their corresponding viral vectors.
Viral infection activates innate immunity by virtue of interaction
with toll-like receptors (TLRs) (McWhirter et al., 2004). The TLRsrecognize pathogen-associated molecular patterns (PAMPs)
associated with viral protein, lipopolysaccharides, DNA or RNA
(Akira and Takeda, 2004; Beutler, 2004; Kato et al., 2005). We
hypothesized that activation of innate immunity through TLRs
may be involved in the difference in gene expression. Indeed,
we observed that our retroviral vectors (but not the CPPs) acti-
vated inflammatory (innate immune response) genes, including
the toll-like receptor 3 (TLR3), NF-kB, IFN-b, Stat1, and Stat2
(data not shown).
TLR3 Signaling Enables Efficient Induction of
Pluripotency Genes by Retroviral Oct4
The TLR-signaling pathway consists of two distinct pathways: a
myeloid differentiation primary response gene (MyD) 88-depen-
dent pathway and a MyD88-independent pathway (Kawai and
Akira, 2010). The MyD88-dependent pathway is common to all
TLRs, except TLR3 (Adachi et al., 1998; Kaisho and Akira,
2006). To distinguish which TLR signaling pathway might be in-
volved in nuclear reprogramming with viral vectors, we used
inhibitory peptides or shRNA knockdown directed against the
MyD88-dependent and -independent pathways.
The TLR3 pathway is activated by viral dsRNA and is indepen-
dent of MyD88. The adaptor for TLR3 is TRIF (for TIR-domain-
containing adaptor-inducing interferon-b) (Yamamoto et al.,
2003). To explore the role of this pathway in the action of retro-
viral reprogramming constructs, we knocked down TLR3 or
TRIF. In addition, we employed a cell permeable peptide inhibitor
of TRIF. As expected, peptide inhibition of the TRIF adaptor
molecule or knockdown by shRNA of TRIF or TLR3 reduced
the activation by pMX-Oct4 of immune response genes (Figures
S2D–S2F). Notably, these knockdowns of TLR3 signaling also
decreased the target and pluripotency gene expression induced
by pMX-Oct4. The peptide inhibitor of TRIF (TRIF-Inh) attenuated
the effect of pMX-Oct4 to induce Oct4 expression (Figure 2A), as
well as expression of the other target genes (Figure 2D). Simi-
larly, shRNA knockdown of TRIF (Figures 2B and 2E), as well
as shRNA knockdown of TLR3 (Figures 2C and 2F), also attenu-
ated the effect of pMX-Oct4 to induce expression of the target
genes.
By contrast, inhibition of MyD88 by an inhibitory peptide
(Figure S2G) or by a stable shRNA knockdown (Figure S2H)
had no effect on the target and pluripotency gene expression
induced by pMX-Oct4. Together, these studies indicate that
TLR3, but not the other TLR pathways, are required for full in-
duction of target gene expression by the retrovirus expression
vector.
TLR3 Signaling Enables Efficient Generation of Human
iPSCs by Retroviral Vectors
To determine whether TLR3 signaling was necessary for efficient
generation of human iPSCs, we assessed retroviral reprogram-
ming in BJ fibroblasts previously treated with scrambled shRNA
or shRNA to knockdown (KD) the expression of TLR3, TRIF, or
MyD88 (Figure 3A). Six days following transduction, the cells
were seeded on mitomycin C-treated mouse embryonic fibro-
blasts (MEFs), and the following day the medium was replaced
with iPSC medium. Around day 25 we observed small colonies
in the Scramble- and MyD88-KD cells; by contrast, no coloniesCell 151, 547–558, October 26, 2012 ª2012 Elsevier Inc. 549
Figure 2. Knockdown of TLR3 Pathway Inhibits Action of Retroviral Vector Encoding Oct4
(A) Gene expression of Oct4 following retroviral-Oct4 (pMX-Oct4) infection is reduced in fibroblasts treated with the TRIF-inhibitory peptide (TRIF-inh).
(B) Gene expression of Oct4 following retroviral-Oct4 (pMX-Oct4) infection is reduced in TRIF shRNA-knockdown fibroblasts. Lower: summary diagram of the
average fold-changes over time in the selected pluripotency genes (Oct4, Sox2, and Nanog) in the four conditions.
(C) Gene expression of Oct4 following retroviral-Oct4 (pMX-Oct4) infection is reduced in TLR3 shRNA-knockdown fibroblasts.
(D–F) Summary figures showing the average fold-changes in the selected genes (i.e., Tcf4, Gap43, Nanog, Sox2 and Oct4) over time for each condition. All data
represented as mean ± S.D., n = 3, *p < 0.005 (see also Figure S2).were observed in the TRIF- or TLR3-KD cells. By day 30, distinct
colonies with typical iPSC colony morphology were noted in
dishes containing the scramble- and MyD88-KD cells (Fig-
ure 3B). At this time, the TRIF- and TLR3-KD cells manifested
only small granulated colonies. It took another 9 days for the
TRIF- and TLR3-KD cells to yield morphologically distinct
iPSC colonies (data not shown). We manually counted each
distinct colony with typical morphological features, as well as
those smaller granulated colonies, appearing from days
30–39 (in two independent experiments by an observer blinded
to the treatment group). As seen in Figure 3C, at early time
points the TRIF- and TLR3-KD cells generated fewer colonies
by comparison to scramble- and MyD88-KD cells. Further-
more, we compared the gene expression values between these
colonies at day 30. The expression of Oct4 (Figure 3D), Sox2,
and Nanog data not shown, were upregulated more than 10-
fold when compared to the TRIF- and TLR3-KD iPSCs. These
findings provide evidence that TLR3 activation is necessary550 Cell 151, 547–558, October 26, 2012 ª2012 Elsevier Inc.for efficient induction of pluripotency genes and generation of
human iPSC colonies by using the approach first described
by Yamanaka.
TLR3 Signaling Enables Efficient Generation of Human
iPSCs by mmRNA Encoding Reprogramming Factors
To determine whether TLR signaling was required for other
methods of reprogramming, we assessed the effects of TLR
knockdowns on mmRNA-based reprogramming. The scramble
or KD human BJ fibroblasts were treated with modified mes-
senger RNA (mmRNA) encoding OSKM (Figure 4A). We ob-
served that when the TLR3 pathway is knocked down (by
using shRNA against TLR3 or TRIF), expression of the pluripo-
tency genes in single colonies is reduced (Figure 4D). Further-
more, we find that TRIF- and TLR3 KD cells generated fewer
colonies by comparison to scramble- and MyD88-KD cells
(Figures 4B and 4C). These observations indicate that TLR3
signaling enables efficient induction of pluripotency by using
Figure 3. TLR3 or TRIF Knockdown Fibroblasts Exhibit Impaired Nuclear Reprogramming
(A) Protocol for iPSC generation using the reprogramming factors, delivered as retroviral vectors.
(B) Representative images of iPSCs on day 30 after initiation of retroviral nuclear reprogramming for scramble, MyD88, TRIF, and TLR3 shRNA knockdown
fibroblasts. In fibroblasts where the TLR3 signaling pathway was knocked down (i.e., TRIF shRNA or TLR3 shRNA cell lines), the development of human iPSC
colonies was markedly delayed. By contrast, in fibroblasts where the adaptor for all other TLRs was knocked down (MyD88 shRNA), no delay in hiPSC
development was noted.
(C) Total number of hiPSC colonies on day 30 in scramble, MyD88, TRIF, and TLR3 shRNA knockdown fibroblast cell lines transduced by the reprogramming
factors delivered by retroviral transfection. The yield of hiPSC colonies was reduced by knocking down the TLR3 signaling pathway. All data represented as
mean ± S.D., *p < 0.05; scramble compared to TRIF or TLR3 shRNA knockdown fibroblasts.
(D) Fold change in Oct4 gene expression in scramble, MyD88, TRIF, and TLR3 shRNA knockdown fibroblasts at day 35.mmRNA, as well as retroviral vectors, encoding the reprogram-
ming factors.
TLR3 Agonist Accelerates CPP-Induced Target Gene
Expression
If TLR3 activation plays a role in the efficiency of viral-based
reprogramming, then the addition of a TLR3 agonist would
be predicted to enhance CPP-induced reprogramming. Poly-
inosinic-polycytidylic acid (Poly I:C) is a synthetic analog of
dsRNA that is recognized specifically by TLR3 and which
induces the expression of genes involved in innate immunity
(data not shown) (Alexopoulou et al., 2001). Accordingly, we as-
sessed the effect of the CPPs alone or in the presence of poly
I:C. The expression of target genes was unaffected by poly I:C
alone. However, when poly I:C (300 ng/ml) was combined with
CPP-SOX2, the expression of the downstream genes was accel-
erated, reproducing the time course of gene expression induced
by pMX-Sox2 (Figures 5A and 5B). We repeated these studies
with CPP-OCT4. When poly I:C was combined with CPP-
OCT4, again the temporal expression of the downstream genes
was accelerated, mimicking the effect observed with the viralvector pMX-Oct4 (Figures 5C and 5D). Furthermore, as seen in
Figures S2A–S2C, the effect of poly I:C to enhance gene expres-
sion of CPP-OCT4 was maintained at later time points. These
studies supported the hypothesis that TLR3 signaling is required
for efficient induction of the target genes of the reprogramming
factors.
TLR3 Activation Enhances Efficiency of a Doxycycline-
Inducible System for Generating iPSCs
To further test the hypothesis that TLR3 activation was required
for efficient reprogramming, we isolated MEFs from murine
embryos expressing a doxycycline (dox)-inducible polycistronic
transgene construct encoding the four reprogramming factors
(Wernig et al., 2008). To generate iPSCs, 105 MEFs/per well in
6-well plates were treated with dox. In some wells, poly I:C
was also added for the initial 6 days of the reprogramming
process. In other wells, cells were infected with pMX-GFP on
the first day of dox treatment. Poly I:C or pMX-GFP each accel-
erated the dox-induced expression ofOct4 andSox2 (Figure 6A).
Poly I:C as well as pMX-GFP accelerated changes in the
morphology of the MEFs with small, compact rounded cellsCell 151, 547–558, October 26, 2012 ª2012 Elsevier Inc. 551
Figure 4. Nuclear Reprogramming Using mmRNA Is Inhibited by TLR3 or TRIF Knockdown
(A) Protocol for iPSC generation using the reprogramming factors, delivered as mmRNA.
(B) Representative images of human iPSCs on day 13 after initiation of mmRNA nuclear reprogramming in the scramble, MyD88, TRIF, and TLR3 shRNA
knockdown fibroblasts. In fibroblasts where the TLR3 signaling pathway was knocked down (i.e., TRIF shRNA or TLR3 shRNA cell lines), the development of
human iPSC colonies was markedly delayed. By contrast, in fibroblasts where the adaptor for other TLRs was knocked down (MyD88 shRNA), no delay in hiPSC
development was noted.
(C) Total number of hiPSC colonies on day 13 in scramble, MyD88, TRIF, and TLR3 shRNA knockdown fibroblast cell lines transduced by the mmRNA re-
programming factors. The yield of hiPSC colonies was reduced by knocking down the TLR3 signaling pathway. All data represented as mean ± S.D., *p < 0.05;
scramble compared to TRIF or TLR3 shRNA knockdown fibroblasts.
(D) Fold change in Oct4 gene expression in individual colonies derived from scramble, MyD88, TRIF, and TLR3 shRNA knockdown fibroblasts at day 13 of their
mmRNA reprogramming.aggregating in the wells at 3 days (data not shown). Similarly,
infection with pMX-GFP accelerated colony formation, as a
number of small colonies were observed by day 7 in the viral
particle infected group (data not shown). By day 14, typical
mES-like colonies appeared, many of which expressed SSEA-1.
At this time point, the number of typical SSEA-1+ colonies
were increased by 7- to 8-fold in wells exposed to viral particles
or poly I:C (Figure 6B). Colony number increased further by days
21–28 (Figures 6B and 6C). These studies strengthened the
hypothesis that TLR3 activation enhances nuclear reprogram-
ming to pluripotency.
TLR3 Activation Enhances CPP-Induced Generation of
Human iPSCs
It is known that persistent expression (about 2 weeks) of the
reprogramming factors using viral vectors is required to gen-
erate mouse iPSCs (Brambrink et al., 2008; Wernig et al.,
2008). We hypothesized that activation of the TLR3 pathway
might facilitate epigenetic alterations required for full transcrip-
tional effect of the CPPs. Accordingly, we exposed human
fibroblasts to the four CPP-transcription factors (OCT4-R11,552 Cell 151, 547–558, October 26, 2012 ª2012 Elsevier Inc.SOX2-R11, KLF4-R11, and CMYC-R11) (at a dose of 200 nM
for days 1–6, and a dose of 100 nM for days 7–21), in the
presence or absence of poly I:C (300 ng/ml) for days 1–6 (Fig-
ure 7A). The cultures were transferred to feeder cells (in-
activated MEFs) at day 26. In the presence of poly I:C, Oct4
expression was accelerated (Figure 7B). Furthermore, poly I:C
accelerated iPSC generation (Figures 7C and 7D). Small colo-
nies were observed by day 21 and ES-like colonies appeared
by day 30, many of which expressed TRA-1-81 as indicated
by live cell staining. By contrast, in human fibroblasts not ex-
posed to poly I:C, colonies were not observed until day 30.
By day 40, colony number was increased by more than 4-fold
in cells exposed to poly I:C (Figure 7C). Human iPSCs induced
by CPP alone (piPSC) or in combination with poly I:C (ppiPSCs)
manifested characteristic ESC morphology, immunoreactivity
for SSEA3 and OCT4, and transcriptional expression (i.e.,
Pou5f1, Sox2, Utf1, Zfp42, and Nanog), and differentiated into
all three embryonic germ layers in vitro and in teratomas (Fig-
ure S3). Thus, CPP-induced reprogramming to pluripotency of
human fibroblasts was enhanced and accelerated by stimula-
tion of TLR signaling.
Figure 5. Poly I:C Accelerates CPP-Induced Target Gene Expression
(A) Relative fold change in gene expression levels of Jarid2 following pMX-Sox2 (red line), CPP-SOX2 (blue line), or poly I:C + CPP-SOX2 (green line) treatments.
(B) Summary figure of these selected genes (i.e., Jarid2,Zic2, bMyb,Oct4,Sox2, andNanog) exhibiting the temporal pattern of average gene expression following
each treatment. Poly I:C markedly enhances the expression of downstream genes by CPP-SOX2.
(C) Relative fold change in gene expression levels of Nanog following pMX-Oct4, CPP-OCT4, or poly I:C + CPP-OCT4 treatments.
(D) Summary figure of these selected genes (i.e., Tcf4, Gap43, Nanog, Sox2, and Oct4) exhibiting the temporal pattern of gene expression following each
treatment. Poly I:C markedly enhances the expression of downstream genes by CPP-OCT4. All data represented as mean ± S.D., n = 3, *p < 0.005 (see also
Figures S4, S5, S6, and S7).TLR3 Activation Enables Epigenetic Changes that Favor
Reprogramming
We hypothesized that TLR3 activation might enhance early
transcriptional activation by inducing an open chromatin state,
permitting the reprogramming factors to induce an ESC-spe-
cific gene expression pattern (Niwa, 2007a, 2007b). Accordingly,
we performed chromatin immunoprecipitation followed by PCR
analysis (ChIP-PCR) to detect trimethylation of histone H3 at
lysine 4 (H3K4me3). This epigenetic modification marks tran-
scriptionally active genes. Human fibroblasts were treated with
pMX-Sox2 or with CPP-SOX2 in the presence of poly I:C or
pMX-GFP. By day 2 of treatment, pMX-Sox2 induced H3K4
trimethylation at the Oct4 promoter (Figure S4A). By contrast,
CPP-SOX2 had no effect at day 2, except in the presence of viral
vector or poly I:C (Figure S4A). (At later time points, CPP-SOX2
alone could induce H3K4 trimethylation, a time lag that reflected
its delayed effects on target gene expression [data not shown]).
Similarly, poly I:C, or the retroviral vector encoding GFP, accel-
erated H3K4 trimethylation at the Sox2 promoter in CPP-treated
fibroblasts (Figure S5A).In a similar fashion, we assessed histone H3 at lysine 9
(H3K9me3) in the Oct4 and Sox2 promoters. This epigenetic
modification marks transcriptionally silenced genes. By day 2
of treatment, pMXSox2 but not CPPSOX2 alone, fully reversed
H3K9 trimethylation at the Oct4 promoter (Figure S4B). Poly
I:C or pMX-GFP enhanced the reversal of H3K9 trimethylation
induced by CPP-SOX2 on day 2 (Figure S4B). (At later time
points, CPP-SOX2 alone could fully reverse H3K9 trimethylation
at the Oct4 promoter after a time lag that reflected its delayed
effects on target gene expression [data not shown]). Similarly,
poly I:C, or the retroviral vector encoding GFP, accelerated the
loss of H3K9 trimethylation at the Sox2 promoter in CPP-treated
fibroblasts (Figure S5B). These studies provided an epigenetic
mechanism to explain the effect of TLR3 activation to enhance
nuclear reprogramming.
TLR3 Activation Regulates Epigenetic Machinery
Histone acetylation status influences the accessibility of DNA to
the transcriptional machinery for gene expression. Histone de-
acetylation is generally associatedwith a closed chromatin state,Cell 151, 547–558, October 26, 2012 ª2012 Elsevier Inc. 553
Figure 6. TLR3 Activation Enhances Reprogramming in a Dox-Inducible System
MEFS containing the dox-inducible polycistronic transgene construct encoding the four reprogramming factors were stimulated by dox, in the absence or
presence of TLR3 activation with poly I:C or the irrelevant retroviral vector pMX-GFP.
(A) Gene expression of Oct4 and Sox2 was accelerated by coadministration of poly I:C, or a retroviral construct encoding GFP.
(B) Histogram showing SSEA-1+ colonies at 2 and 3 weeks in primary plates. Coadministration of poly I:C, or a retroviral construct encoding GFP, markedly
increased the yield of dox-induced reprogramming.
(C) SSEA-1 live staining showing iPSC colonies derived from dox-inducible MEFs 4 weeks after exposure to dox. In some wells, MEFs were also exposed to
a retroviral construct encoding GFP, or to poly I:C (see also Figures S6 and S7).and inhibitors of histone deacetylase (HDAC) such as valproic
acid are employed to enhance nuclear reprogramming. There-
fore it is notable that poly I:C downregulated the expression of
a suite of HDAC genes in CPP-treated human fibroblasts (Table
S1). The downregulation of HDAC1 expression by poly I:C or by
pMX-GFP was confirmed by western analysis (Figures S4C and
S4D). Similar downregulation of the HDAC family by poly I:C was
noted in the dox-inducible MEFs described above and in Fig-
ure 5. To determine whether the effect of poly I:C on epigenetic
modifiers was dependent upon TLR3 signaling, we repeated
these studies in the TLR knockdown lines. As anticipated, poly
I:C reduced HDAC1 expression in the scrambled or Myd88
KD lines, but failed to downregulate HDAC1 expression in the
TRIF- and TLR3-KD lines (Figure S5C). These studies indicated
that activation of TLR3 signaling causes changes in epigenetic
modifiers that favor reprogramming.
Poly I:C affected the expression of other epigenetic modifiers
(Table S1). In addition, the changes in methylation status of the
Oct4 and Sox2 promoters that were accelerated by TLR3 acti-
vation were also associated with an accelerated redistribution
of heterochromatin protein 1 (HP1; data not shown). HP1 bound
to methylated H3K9 recruits the methylase Suv39h, leading to
further methylation of H3K9, so as to consolidate a repressed
state (Bannister et al., 2001; Lachner et al., 2001). The redistribu-554 Cell 151, 547–558, October 26, 2012 ª2012 Elsevier Inc.tion of HP1 induced by poly I:C is consistent with genome-
wide epigenetic alterations promoted by TLR3 activation, and
directed by the reprogramming factors.
Role of NF-kB in TLR-Mediated Regulation of Epigenetic
Machinery
Histone acetylation favors an open chromatin state, maintained
by proteins containing histone acetyltransferase (HAT) domains,
such as p300 and CBP. NF-kB is a transcriptional effector
of TLR3 activation (Hayden and Ghosh, 2004; Hayden et al.,
2006) and interacts with CBP/p300 to positively regulate gene
expression (Farlik et al., 2010; Li and Verma, 2002). We used
a luciferase reporter assay system to document that poly I:C,
but not the CPPs alone, induced NF-kB activation (Figure S6A).
This effect was mediated by TLR3, as shRNA knockdown of
TLR3 or its adaptor protein TRIF reduced the effect of poly I:C
on NF-kB activation (Figure S6A). Similarly, the retroviral con-
structs, as well as poly I:C, induced a sustained increase in the
expression of NF-kB and Tlr3, whereas CPP-SOX2 did not (Fig-
ure S6A). These studies suggest that the effect of TLR3 activa-
tion to induce changes in gene expression of the epigenetic
machinery might be mediated in part by NF-kB.
To further elucidate the elements of TLR3 signaling involved in
reprogramming, we inhibited the action of downstream effectors
Figure 7. TLR3 Activation Stimulates CPP-Induced Reprogramming of Human Fibroblasts
(A) Protocol for human iPSC generation using four CPP-TFs (OCT4-R11, SOX2-R11, KLF4-R11, and cMYC-R11).
(B) Gene expression of Oct4 was increased by coadministration of poly I:C, by day 30-45.
(C) TRA-1-81 positive colonies counted at day 30 and day 40 in the presence and absence of poly I:C. Coadministration of poly I:Cmarkedly increased the yield of
CPP-induced reprogramming. All data represented as mean ± S.D., n = 3, *p < 0.01.
(D) ES-like colony formation at day 32 of CPP-induced transactivation (103) (see also Figures S3, S4, S5, S6, and S7 and Table S1).IKKε, NF-kB, and IRF3. As before, we found that poly I:C
enhanced reprogramming of dox-inducible MEFs. This effect
of poly I:C to induce NF-kB translocation to the nucleus (Fig-
ure S6B), and to increase colony formation (Figure S6D), was
markedly reduced by the addition of p65 decoy. In additional
experiments, shRNA knockdown of IRF3 or IKK (Figure S6C)
also impaired iPSC generation (Figure S6D). These studies indi-
cated that TLR3-induced activation of both NF-kB and IRF3
were required for efficient reprogramming.
To further document a role for these transcriptional factors
in TLR3-facilitated chromatin modification, we performed ChIP
assay for H3K4me3 and H3K27me3. We observed that the inhi-
bition of NF-kB, IRF3 or IKKε fully eliminated H3K4 trimethylation
at theOct4 promoter after dox stimulation in the presence of poly
I:C (Figure S7A). Furthermore, H3K27 trimethylation of the Oct4
promoter was increased upon inhibition of the innate immune
pathway (Figure S7B).
In the reprogramming dox-inducible MEFs, the addition of
poly I:C induced changes in the expression in a set of enzymes
involved in chromatin modification (Figure S7C). We observed
that poly I:C upregulated histone acetyltransferase (i.e., Hat1
and Esco2) and histone methyltransferase (Smyd) as well as
downregulated the histone deacetylase family (i.e., Hdac 5, 8,
9, and 10), H3K4 histone methyltransferase (Ash1l) and H3K79
histone methyltransferase (Dot1L). Inhibition of the latter methyl-transferase is critical in somatic cell reprogramming (Onder et al.,
2012). Notably, the effects of poly I:C on these epigenetic modi-
fiers was reversed by decoy oligonucleotide inhibition of NF-kB
(Figure S7D).
DISCUSSION
This report posits a direct link between nuclear reprogramming
efficiency and inflammatory pathways in the induction of plurip-
otency. In seeking to induce pluripotency while employing CPPs,
we serendipitously discovered a role for innate immunity sig-
naling in effective nuclear reprogramming. Our salient observa-
tions are: (1) A consistent difference in the temporal characteris-
tics of gene expression is observed between cells exposed to
the reprogramming factors in the formof retroviral vectors versus
CPPs. (2) This difference is reversed by combining CPPs with
TLR3 agonists. (3) TLR3 knockdown inhibits the activation of
downstream pluripotency genes when using retroviral vectors
or mmRNA to overexpress the reprogramming factors and re-
duces the efficiency and yield of human iPSC generation. (4)
TLR3 activation enhances the efficiency and yield of miPSC
generation in a dox-inducible system; and enhances the effi-
ciency and yield of human iPSC generation when using the re-
programming factors in the form of CPPs, and (5) TLR3 activation
enables epigenetic alterations, including changes in methylationCell 151, 547–558, October 26, 2012 ª2012 Elsevier Inc. 555
status of the Oct4 and Sox2 promoters as well as changes in the
expression of epigenetic effectors, that promote an open chro-
matin configuration. The knowledge that the activation of innate
immune response affects nuclear reprogramming permitted us
to enhance the efficiency and yield of human iPSCs by using
reprogramming factors in the form of CPPs.
An Unappreciated Role for TLR3 Activity in
Reprogramming
TLR3 recognizes double-stranded RNA (dsRNA) generated by
retroviruses (Agger et al., 2007; DeSanta et al., 2007). The impor-
tance of TLR signaling for effective nuclear reprogramming
has not been appreciated. We show that the efficiency and yield
of human iPSC generation, using retroviral vectors, is reduced
by knockdown of the pathway with peptide inhibitors or shRNA
knockdown of TLR3 or its adaptor protein TRIF. This effect of
TLR3 knockdown is also observed when using mmRNA to ex-
press the reprogramming factors.
We confirmed the importance of TLR signaling in a virus-
free system by using murine embryonic fibroblasts that were
genetically engineered to express a dox-inducible cassette en-
coding the reprogramming factors. In this system, the coad-
ministration of the TLR3 agonist poly I:C increased the efficiency
and yield of murine iPSCs (Figure 6). Notably, the same effect
was observed with coadministration of the retrovirus encoding
GFP, which retrovirus would be expected to activate TLR3
without otherwise affecting the nuclear reprogramming process.
Our work indicates that the retroviral vectors used for inducing
pluripotency are more than vehicles for delivering the repro-
gramming factors and actively contribute to the reprogramming
process.
It is worth noting that there seems to be an optimal level of
TLR3 activation. Because retroviral vectors activate the TLR3
pathway, further activation does not seem to be necessary
during reprogramming with retroviral vectors and may even be
counterproductive. Higher levels of activation are associated
with less colony formation, probably due to cell death (data not
shown).
TLR3 and Epigenetic Modification
The effect of TLR3 activation to enhance the yield and efficiency
of human iPSC generation is due in part to its regulation of the
expression and/or distribution of epigenetic modifiers (Table
S1; Figures 7, S4C, S4D, and S5C). Associated with the changes
in expression of epigenetic modifiers, we observed histone
modifications consistent with an open chromatin configuration
on the promoter regions of Oct4 and Sox2 (Figures S4 and S5).
Notably, however, the increase in H3K4 trimethylation and the
decrease in H3K9 trimethylation of these promoters were not
observed with TLR3 activation alone. Only in the presence of
the CPPs did poly I:C induce changes in these methylation
marks. This observation supports the concept that, although
TLR3 activation causes widespread changes in the expression
of epigenetic modifiers that might promote the open chromatin
configuration of pluripotency genes, the reprogramming proteins
are likely necessary to direct the epigenetic modifiers to the
appropriate promoter sequences. This notion is also supported
by the confocal images of HP1a distribution (data not shown).556 Cell 151, 547–558, October 26, 2012 ª2012 Elsevier Inc.Heterochromatin protein1 (HP1) is associated with the closed
conformation of chromatin. Although we did not see changes
in the expression levels of HP1 expression (Figures S4C and
S4D), we observed marked changes in its distribution when
CPP-SOX2 was coadministered with poly I:C or with the retro-
viral vector encoding GFP. However, in the absence of the
CPP, there was no observable redistribution of HP1 induced
by poly I:C or the retroviral vector alone.
Any of five classes of pathogen recognition receptors (PRRs)
have been shown to signal in ways that are comparable to
TLR3 (Roy andMocarski, 2007) and might be expected to accel-
erate nuclear reprogramming. The fact that the current work
implicated TRIF (Choe et al., 2005) signaling aligns with the
fact that the retrovirus RNA, or the mmRNA, triggers TLR3 sig-
naling to engage NF-kB, IRF3, and IFNb. Other TLR or PRRs
drive a similar inflammatory response converging on NF-kB,
IRF3, and IFNb (Akira and Takeda, 2004).
Type 1 interferons (e.g., IFNb) are elaborated during exposure
tommRNA or viral vectors, and we have not ruled out their role in
reprogramming efficiency. In addition, silencing of endogenous
retrotransposons is characteristic of the fully reprogrammed
pluripotent state (Brambrink et al., 2008; Stadtfeld et al., 2008;
Wernig et al., 2008). Notably, IRF3 induces expression of the
tripartite motif (TRIM) protein family, which is implicated in
silencing of endogenous retroelements in ES cells (Wolf and
Goff, 2007). We observed that poly I:C induces the expression
of the TRIM family (Table S1), and this effect of TLR3 activation
may play a role in the reprogramming process by silencing en-
dogenous retrotransposons.
In any event, our data suggest that activation of inflammatory
pathways enhance nuclear reprogramming. Innate immunity
signaling appears to favor an open chromatin state, which in-
creases cell plasticity in response to a pathogen. We speculate
that this cell state may enhance induction of pluripotentiality,
transdifferentiation, or even malignant transformation and is
characterized by global changes in epigenetic modifiers in a
process we term ‘‘transflammation.’’
CONCLUSION
Our observations highlight a previously unrecognized role for
innate immunity activation in nuclear reprogramming. The viral
vectors or mmRNA constructs used to induce pluripotency are
more than mere vehicles for the reprogramming factors. Innate
immune activation causes striking changes in epigenetic modi-
fiers that favor an open chromatin configuration. These changes
enable a fluidity of cell phenotype that contributes to successful
nuclear reprogramming.
EXPERIMENTAL PROCEDURES
Cells
BJ human fibroblast cells (Stemgent) were cultured in DMEM with 10% FBS
and 1% penicillin/streptomycin (5% CO2, 37
C). For isolation of secondary
dox-inducible MEFs, chimeric embryos were obtained from transgenic
R26rtTA;Col1a12lox-4F2A mice expressing the loxP-flanked, dox-inducible poly-
cistronic 4F2A cassette (Oct4, Sox2, Klf4, c-Myc; Jackson Laboratory).
Secondary MEFS were isolated as previously described (Wernig et al.,
2008), and expanded for two passages before freezing.
Viral Preparation and Infection
HEK293FT cells were plated at 6 3 106 cells per T225 flask and incubated
overnight. Cells were transfected with 10 mg of VSV-G (envelope protein),
15 mg of pUMVC (packaging plasmid), and 10 mg of gene of interest (Sox2
or Oct4) with Lipofectamine. 48 hr after transfection, the supernatant of
transfectant was collected and filtered (0.45 mm filter). Following spinning at
17,100 rpm for 2.3 hr, the viral pellet was resuspended to make 1003 stock
solutions. Human fibroblasts (5 3 104 cells/well) were seeded a day before
transduction. The medium was replaced with virus-containing supernatant
supplemented with 8 mg/ml polybrene, and incubated for 24 hr.
Treatments
At 60%–70% confluency, BJ fibroblast cells were serum-starved (1% serum)
to induce G1 cell cycle arrest and then subjected to either a single infection
with retroviral constructs or daily treatments with 200 nM CPPs (CPP-SOX2
or CPP-OCT4). Poly I:C (300 ng/ml) was added to the cells simultaneously
with the CPPs. For experiments involving peptide inhibitors, cells were pre-
treated for 6 hr at 40 mM with either MyD88 inhibitory peptide (Pepinh-MyD)
or TRIF inhibitory peptide (Pepinh-TRIF) followed by CPP treatments.
Gene Expression and Microarray Analyses
RNA was isolated (RNeasy), first-strand cDNA primed with oligo(dT) primers,
and qPCR performed (primer sets from Applied Biosystems). RNA probes
were prepared and hybridized to Illumina HumanHT-12 v4 Expression Bead-
Chip microarrays.
Short Hairpin RNA Design
Short hairpin RNA was obtained from Invivogen. Target sequences: MyD88
shRNA, AACTGGAACAGACAAACTATC; TRIF shRNA, AAGACCAGACGCCA
CTCCAAC; and TLR3 shRNA, GCTTGGCTTCCACAACTAGAA.
Chromatin Immunoprecipitation and Chromatin
Immunoprecipitation-qPCR
Quantitative chromatin immunoprecipitation (qChIP) was performed (Lim
et al., 2009; Peng et al., 2009). For qChIP and qRT-PCR, error estimates are
standard deviations. Recovery of genomic DNA as the percentage input was
calculated as the ratio of copy numbers in the immunoprecipitate to the input
control. Primers of Oct4 and Sox2 promoters were purchased from Cell
Signaling.
Generation of iPSCs
Retroviral iPSCs
Human fibroblasts previously treated with MyD88, TRIF, TLR3, or Scramble
shRNA were transduced with pMX-Oct4, pMX-Sox2, pMX-Klf4, and pMX-
cMyc retroviruses (Takahashi et al., 2007; Takahashi and Yamanaka, 2006)
and were cultured in iPSC medium on mitomycin-treated MEFs. Colonies
were counted over time and were harvested for RNA isolation qPCR analysis
for pluripotency gene expression.
Protein iPSCs
Recombinant Oct4, Sox2, Klf4, and cMyc human proteins (CPPs) contained
an 11-arginine membrane penetration domain at the C terminus (Stemgent).
Human fibroblasts were treated with CPP-OCT4, CPP-SOX2, CPP-KLF4,
and CPP-cMYC daily for 6 days (200 nM), then daily from days 7–20
(100 nM). Poly I:C (300 ng/ml) or vehicle was added to the cell simultaneously
up to day 6. The cells were passed ontoMEF feeders at day 30. After 20 days of
CPP treatments, wells were scanned for colonies.
Dox-Induced iPSCs
A total of 4 3 104/well secondary MEFs (passage #4) were plated and treated
with dox (2 mg/ml) ± poly I:C (300 ng/ml). The generation of iPSC colonies was
scored at days 14 and 21.
Induction of Pluripotency Using mmRNA
Knockdown human fibroblasts were transduced with mmRNA encoding
OSKM and were cultured in iPSC medium on mitomycin-treated MEFs
(Yakubov et al., 2010). Colonies were counted by day 13, and single colonies
were harvested for RNA isolation and qPCR analysis for pluripotency gene
expression.NF-kB Luciferase Assay
BJ fibroblasts (3 3 105/well) were subjected to either pMX-GFP infection or
CPP-SOX2 treatment with or without poly I:C (300 ng/ml). Cells were trans-
fected with pNF-kB-Luc and pFC-MEKK as a positive control plasmid by using
Lipofectamine 2000, and after 24 hr cells were studied by using the Bright-Glo
Luciferase Assay System and a luminometer.
Immunostaining of Live Cells
For the detection of SSEA-1 or TRA-1-81 in live cells, the primary Ab (anti-
mouse SSEA-1, anti-human TRA-1-81; Stemgent) was diluted to a final
concentration of 2.5 to 5 mg/ml in cell culture medium and incubated with cells
for 30 min (37C, 5% CO2). After gentle washing, the cells were examined
under a fluorescent microscope.
Western Blotting
Proteins were extracted from BJ fibroblasts by solubilizing the cells in RIPA
buffer containing 13 protease inhibitor cocktail. Twenty-five micrograms of
total protein was loaded and resolved on SDS-polyacrylamide gels, trans-
ferred to polyvinylidene fluoride membranes and probed with Abs against
HP1a, HDAC1 (Cell Signaling), and b-ACTIN (Sigma, A5441). Immunoblots
were developed with enhanced chemiluminescence reagents (Amersham).
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